Clinical Research Directory
Browse clinical research sites, groups, and studies.
Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
The purpose of this study is to learn about possible changes in cognitive (mental) abilities, such as memory skills and concentration, and in brain anatomy (structure) and function, in people with lymphoma receiving CAR-T therapy.
Official title: A Study of Longitudinal Neurocognitive and Neuroimaging Evaluations for Adult Patients With Lymphoma Receiving CD19 CAR T Cell Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2019-09-25
Completion Date
2026-09
Last Updated
2025-10-24
Healthy Volunteers
No
Conditions
Interventions
neurocognitive evaluations
The test battery consists of validated and reliable measures of attention, executive functions and memory.
brain MRIs
Patients will undergo baseline and follow-up research MRIs in the same scanner at MSKCC (3 Tesla scanner (GE, Discovery 750W, USA) with a GEM HNU 24-channel head coil) (total scan duration=15 minutes).
Blood samples
Research blood samples will be collected pre-CAR T infusion; day of CART infusion (day 0), and post-infusion days 7, 14, 21, 28 (+/- 7 days), at start of neurotoxicity, and at 3-4 months and 6-7 months post-CART.
Locations (1)
Memorial Sloan Kettering Cancer Center
New York, New York, United States